Serotonin syndrome due to duloxetine

Area of Science:

• Pharmacology
• Clinical Toxicology

Background:

• Serotonin syndrome is a potentially life-threatening condition resulting from excessive serotonergic activity.
• It is primarily caused by serotonergic medications, often due to overdose or drug interactions.
• Accurate diagnosis can be challenging due to its purely clinical nature and lack of definitive validation.

Observation:

• A patient presented with symptoms including tremor, mydriatic pupils, clonus, and ataxia.
• These symptoms emerged after a single therapeutic dose of duloxetine, an antidepressant.
• Duloxetine is classified as a serotonin-norepinephrine reuptake inhibitor (SNRI).

Findings:

• This case represents a rare instance of serotonin syndrome associated with duloxetine.
• The clinical presentation aligns with established criteria for serotonin syndrome.
• The event occurred at a standard admission dosage, not an overdose.

Implications:

• The increasing availability of serotonergic agents necessitates heightened awareness of potential toxicities.
• Serotonin syndrome, though complex, is often preventable and recognizable.
• Clinicians should consider duloxetine as a potential cause of serotonin syndrome, even at therapeutic doses.